Soleno Therapeutics (SLNO) is down -26.7%, or -$17.06 to $46.79.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO:
- Soleno Therapeutics price target lowered to $106 from $123 at Wells Fargo
- Soleno Therapeutics Achieves Profitability with VYKAT XR Launch
- Soleno Therapeutics: Strong Sales Growth and Profitability Drive Buy Rating
- Closing Bell Movers: AMD falls 4% on earnings, Trex, Pinterest down sharply
- Soleno Therapeutics reports Q3 EPS 47c, consensus 6c